The current price of ENTA is $10.08 — it has decreased by 5.35% since the previous close. Data as of Nov 5, 2026.
ENTA is down 9.03% over the past week, down 20.00% over the past month and down 7.69% over the past year. The price is below its 200-day moving average of $13.16.
Analysts' average 12-month price target for ENTA is $20.00, which implies 98.41% upside from the current price. Individual estimates range from $20.00 to $20.00.
Of the 6 analysts covering Enanta Pharmaceuticals, Inc., 1 rates it a strong buy and 5 rate it a buy. The overall consensus is bullish. Analyst ratings are opinions and do not guarantee future performance.
Enanta Pharmaceuticals, Inc. has a market capitalization of $293.58M. The company belongs to the Healthcare sector. Compare it with other companies in the stock screener.
In its most recent quarterly report, Enanta Pharmaceuticals, Inc. posted a loss of $0.67 per share against an estimate of -$0.5095, missing expectations by 31.50%. Upcoming reports are listed in the earnings calendar.
Enanta Pharmaceuticals, Inc. reported revenue of $14.36M in its most recent quarter, which has decreased by 21.60% compared with the same quarter a year earlier. Analysts had expected $16.76M.
Enanta Pharmaceuticals, Inc. has not paid any dividends over the past year.
Companies most comparable to Enanta Pharmaceuticals, Inc. include Assembly Biosciences, Inc., Atea Pharmaceuticals, Inc., Prelude Therapeutics Incorporated, Nautilus Biotechnolgy, Inc. and Immuneering Corporation.
In the latest trading session ENTA moved between $10.06 and $11.07, a range of 10.02% of its current price.
Investing in stocks requires thorough research: study the company's financials, related news and technical analysis before making a decision. Technical analysis of Enanta Pharmaceuticals, Inc. shows a sell rating today and a strong sell rating on the weekly timeframe. Market conditions change quickly, so it is worth looking further ahead as well — the 1-month rating for Enanta Pharmaceuticals, Inc. is sell. Technical ratings are indicators, not investment advice.
Over the past 52 weeks ENTA has traded between $10.05 and $17.15. The current price is 41.22% below its 52-week high.
Figures as of Nov 5, 2026. This information is provided for general purposes only and is not investment advice.